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In-vitro evaluation of the PediaSat continuous central venous
oxygenation monitoring system
Abstract
BACKGROUND AND OBJECTIVE: In-vitro performance of the PediaSat system for continuous
monitoring of central venous oxygen saturation by spectrophotometry has been evaluated. METHODS:
PediaSat continuous fibre-optic oximetry catheters were inserted in a black testing chamber, connected
with an extracorporeal circuit and filled with human whole blood. Oxygen inflow into the
cardiopulmonary bypass system was varied, and the testing chamber was perfused with blood flow of
1000 ml min. Oxygen saturation values measured by PediaSat (SPediaSatO2) were compared with
cooximetry (SCO-OXO2) values from simultaneously taken blood samples by Bland-Altman and
simple regression analyses. RESULTS: Fifty data pairs were obtained. SPediaSatO2 and SCO-OXO2
values ranged between 28-98 and 24.9-99.5%, respectively. Correlation between SPediSatO2 and
SCO-OXO2 was high with an r value equal to 0.96 (P < 0.0001). Overall, SPediaSatO2 only slightly
overestimated SCO-OXO2 (mean bias +2.9%), and limits of agreement (+/-2 SD of bias) were
acceptable (-6.8/+12.6%). Sensitivity and specificity of the first differences of SPediaSatO2 and
SCO-OXO2 were 1.0 and 0.92, respectively. Subgroup analysis of SCO-OXO2 values below 70%
resulted in an overestimation by SPediaSatO2, with a mean bias of +5.2% and limits of agreement of
-4.7 and +15.1%. CONCLUSION: The current version of the PediaSat system does not reliably reflect
SCO-OXO2 values below 70%, but it seems to be a useful tool providing an accurate trend of
continuous central venous oxygen saturation.
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Summary  
 
Background and objective In vitro performance of the PediaSat system for continuous 
monitoring of central venous oxygen saturation by spectrophotometry has been evaluated.  
Methods PediaSat continuous fiberoptic oximetry catheters were inserted in a black testing 
chamber, connected with an extracorporeal circuit and filled with human whole blood. 
Oxygen inflow into the cardio-pulmonary bypass system was varied and the testing chamber 
was perfused with blood flow of 1000 ml.min-1. Oxygen saturation values measured by 
PediaSat (SPediaSatO2) were compared with co-oximetry (SCO-OXO2) values from 
simultaneously taken blood samples by Bland-Altman and simple regression analysis. 
Results Fifty data pairs were obtained. SPediaSatO2 and SCO-OXO2 values ranged between 28 - 
98% and 24.9 – 99.5% respectively. Correlation between SPediSatO2 and SCO-OXO2 was high 
with r2 = 0.96 (p < 0.0001). Overall, SPediaSatO2 only slightly overestimated SCO-OXO2 (mean 
bias +2.9%), and limits of agreement (± 2 SD of bias) were acceptable (–6.8 / +12.6%). 
Sensitivity and specificity of the first differences of SPediaSatO2 and SCO-OXO2 were 1.0 and 
0.92, respectively. Subgroup analysis of SCO-OXO2 values below 70% resulted in an 
overestimation by SPediaSatO2 with a mean bias of +5.2% and limits of agreement of - 4.7 and + 
15.1%. 
Conclusions The current version of the PediaSat system does not reliably reflect SCO-OXO2 
values below 70%, but it seems to be a useful tool providing accurate trend of continuous 
ScvO2. 
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Introduction 
 
Mixed venous oxygen saturation (SvO2) assessed by a pulmonary artery catheter has been 
used for many years to estimate the DO2/VO2 balance. Recently central venous oxygen 
saturation (ScvO2) has replaced SvO2 in many clinical settings [1, 2] and is one of the core 
targets for early goal-directed therapy in the treatment of septic shock in adults [3-5]. The role 
of ScvO2 is even more important in neonates and paediatric patients, in whom the positioning 
of a pulmonary artery catheter is problematic. The detection of variation of ScvO2 values has 
become a point of interest particularly in the perioperative setting of cardiac and major 
surgery [6] in high risk patients. Standard means of monitoring ScvO2 to assess global oxygen 
balance and cardiac output in paediatric patients consist of repeated blood sampling from a 
central venous catheter placed in the superior vena cava and analysis of the blood using co-
oximetry [7]. This approach is intermittent, is attendant on increased workload and costs and 
results in contamination of stopcocks and iatrogenic blood loss. Additionally, haemodynamic 
and metabolic conditions may vary rapidly and are often not detected by intermittent blood 
gas analysis. Techniques providing continuous monitoring of ScvO2 may be a real time 
answer to this substantial issue. 
Spectrophotometry using near-infrared light [7] is one of these technologies, and several 
devices have been commercially introduced. Various devices has been evaluated in few 
clinical and experimental investigations, but the results remain controversial [8-12].  Recently 
a new system for paediatric patients, the PediaSat system (Edwards lifesciences, Irvine, CA 
92614, USA) has become available, using central venous catheters with inbuilt fibre-optic 
transmission. The aim of this study was to validate its performance in an in vitro bench top 
model. 
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Methods 
 
The PediaSat system consists of a central venous catheter with inbuilt spectrophotometric 
probe containing two fibre-optic lines connected proximally to the optical module of the 
PediaSat system. Three different catheters 4Fr 1-Lumen, 4.5 2 Lumen and 5.5 Fr. 3 Lumen 
central venous catheters with fibre-optic probes are available. 
For the purpose of monitoring SPediaSatO2, light of two wavelengths (660 and 800 nm) is 
transmitted through one of the two fibre-optic lines. Tissue chromophores, such as 
haemoglobin, absorb near-infrared light, depending on their oxygenation state. Changes in 
chromophore concentrations and oxygenation states, revealed by comparing emitted and 
detected near-infrared light, can therefore be quantified, using the modified Lambert-Beer law 
[8, 13, 14]. Light reflected from the haemoglobin in the red blood cells is detected by the 
second fibre-optic line of the probe and transmitted back to the sensor in the optical module. 
The sensor in the optical module of the PediaSat device determines light extinction and 
SPediaSatO2 is calculated and displayed on the screen of the VigileoTM Monitor (Vigileo 
Monitor MHM1E, Edwards Lifesciences, Irvine, CA 92614, USA).  
Before starting continuous measurements, a calibrating manoeuver using a blood sample 
analysed by co-oximetry is required according to the manufacturer’s instructional 
recommendations.  During continuous recording of oxygen saturation, the Vigileo monitor 
displays a “signal quality index (SQI)” in a 4-degree range from 1 (best quality) to 4 (worst 
quality). The SQI is a composite signal that expresses the signal intensity, the blood 
pulsatility, and the presence of outlying spikes in the re/infrared signal.   
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Experimental set-up 
Two 6.0F introducer sheaths (Avanti®+ Catheter Sheath Introducer, Cordis Cooperation, East 
Bridgewater, NJ, USA) with a length of 7.5 cm and a distal lumen of 2.2 mm (Pulsion 
Medical Systems) were inbuilt into two separated chambers of a black test box of 100 cm3. 
The two chambers were connected to provide blood flow through both of them. Two 3 lumen 
- PediSatTM oximetry catheters (XT3515HS, 5.5-F, 1.83mm, 15cm; Edwards Lifesciences, 
Irvine, CA, USA) were introduced into the distal lumen of the introducer sheets until about 8 
cm of the length of the catheter, then secured by the integrated luer-lock system. Each catheter 
was then connected to the optical module of one of two VigeleoTM Monitors (Edwards 
Lifesciences, Irvine, CA, USA). The black box was connected to a paediatric 
cardiopulmonary bypass (CPB) circuit. The configuration of the CPB circuit included a roller 
pump and a thermoregulating device (Paediatric Pump S3, Stöckert Instruments, Munich, 
Germany), a Safe Mini oxygenator (Polystan/Maquet-CP, Hirlingen, Germany), a Safe Micro 
Reservoir (Polystan/Maquet-CP) and a real-time blood gas analyser unit (CDI 500, Terumo, 
Eschborn, Germany) to monitor PCO2. Pressurized O2, N2 and CO2 were connected to a fresh 
gas mixer (full automatic gas blender, Stöckert Instruments) (Fig 1) to provide air mixtures 
with various concentrations of oxygen and physiological PCO2. The CPB circuit was filled up 
with 300 ml of heparinized (10’000 heparin sodium (Hoffman la Roche AG, Grenzach-
Wyhlen, Germany) human full blood provided by one of the investigators; the air was 
completely expelled. The flow rate provided by the roller pump was kept constant at 1000 
ml.min-1 throughout the experiments, and blood pressure in the test chamber was held at 15 
mmHg. Blood was warmed up to 37°C, and alpha-stat blood PCO2 was held within 
physiological range (5-7 kPa) by external CO2 gas source, as continuously monitored by the 
real-time blood gas analyser unit (CDI 500, Terumo, Eschborn, Germany) of the 
extracorporeal circuit and confirmed by blood gas analysis.  
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After obtaining steady-state values for SPediStatO2 at 70%, both PediaSat systems were 
calibrated according to the instructions of the manufacturer. If SQI was higher than two, the 
optical fibre was removed, cleaned and reintroduced into the introducer. Only SQI values ≤ 2 
were accepted. After initial de-saturation of the circulating blood by gradually changing the 
fresh gas mixture of the membrane oxygenator from oxygen to nitrogen, subsequent 
saturations were performed by increasing oxygenation of the fresh gas mixture. 
With each change of the oxygen saturation level and under steady-state, the SPediaSatO2, values  
were recorded. Simultaneously, blood samples were taken from the distal lumen of the 
introducer sheet, the oxygen saturation and haemoglobin concentration (Hb) were measured 
by multi-wavelength co-oximetry (SCO-OXO2) (GEM®OPLTM, Instrumentation Laboratory, 
Lexington, Massachusetts, USA) as well as pH, partial oxygen tension (PaO2), partial carbon 
dioxide tension (PaCO2), and bicarbonate base excess (GEM PremierTM 3000 with iQM, 
Instrumentation Laboratory, Lexington, MA, USA). Two series of measurements were done 
on two occasions, using identical experimental set-ups and, for each set-up, two new fibre-
optic central venous catheters were used. 
 
Statistics 
Data were expressed as mean (SD). Agreement between SPediaSatO2 and SCO-OXO2 was 
assessed by Bland-Altman analysis [15]. Linear regression analysis was performed to 
compare SPediaSatO2 and SCO-OXO2 and the difference values of SPediaSatO2 and SCO-OXO2 with 
SCO-OXO2. Sensitivity /Specificity of  SPediSatO2 between two consecutive readings to 
indicate fall or increase of SCO-OXO2 was calculated. Intra-class correlation was computed to 
quantify importance of differences between the experiments. Levene’s test of equality of 
variances was performed to analyze the variation between the experiments. An analysis of 
covariance was performed to analyze the effects of the experiment and the dependence of the 
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difference values of SPediaSatO2 and SCO-OXO2 on SCO-OXO2. SPSS version 16.1 (SPSS Inc, 
Chicago, USA) was used from the hospital resources for this purpose. 
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Results  
 
A total of fifty SPediaSatO2 readings and simultaneous measurements of SCO-OXO2 were obtained 
and analysed. Metabolic parameters are listed in Table 1. SPediaSatO2 and SCO-OXO2 values 
ranged between 28 - 98% and 24.9 – 99.5% respectively. Inter-probe reliability of SPediaSatO2 
values detected by the two simultaneously used PediaSat catheters showed a bias of 4% and a 
precision of 4 % (r2 = 0.99; p < 0.0001; Fig 2). 
Linear regression analysis demonstrated a high correlation between SPediaSatO2 and SCO-OXO2 
(r2 = 0.96; p < 0.0001; Fig 3). Overall, SPediaSatO2 only slightly overestimated SCO-OXO2 (mean 
bias +2.9%), however limits of agreement (Bias ± 2 SD of mean difference) were less 
acceptable with –6.8 / +12.6% (Fig 3). The differences between SPediaSatO2 and SCO-OXO2  
significantly depended on SCO-OXO2.  
SCO-OXO2 values above 70% resulted in a  better agreement between SPediaSatO2 and SCO-OXO2 
with a mean bias of 0.4% and limits of agreement of – 6.0 and + 6.8% (Fig 4), whereas SCO-
OXO2 values below 70% represented an overestimation of SPediaSatO2 with a mean bias of 
+5.2%  and limits of agreement of - 4.7 and + 15.1% (Fig 4).  
Sensitivity and specificity of SPediaSatO2 to indicate a fall or raise of SCO-OXO2  between two 
subsequent measurements were 1.0 and 0.92, respectively. 
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Discussion 
This bench top in-vitro set up investigated reliability of the PediaSat system for continuous 
monitoring central venous oxygen saturation. The main findings were that PediaSat system 
considerably overestimated SvO2 values at SCO-OXO2 values < of 70%, however sensitivity 
and specificity of SPediaSatO2 to indicate deterioration or improvement of SCO-OXO2 were 
acceptable.  
The PediaSat system, investigated in this study, is based on reflectance oximetry using two 
reference light wave-lengths and is characterised by one transmitting and one detecting fibre-
optic filaments. The PediaSat system is easy to handle, does not necessitate additional 
invasive venous access and allows in-vivo calibration. Calibration manoeuver is 
recommended once a day by the manufacturer. Additionally, it is applicable in neonates, 
infants and children since three different sizes of the oximetry catheters are available. 
Disadvantages are the increased stiffness of the catheter and the necessity of updating the 
haemoglobin and haematocrit value if significant shifts of haemoglobin (> 1.8g/dl) or 
haematocrit (> 6%) occur.  
Based on our findings, SPediaSatO2 considerably overestimated SvO2 values at SCO-OXO2 values 
< 70%. The reliability of ScvO2 readings is of particular importance in this lower range (< 
60%), where changes become of vital interest and therapeutic interventions become 
necessary. Even more, during and after palliative congenital cardiac surgery in neonates and 
small infants with cyanotic heart diseases ScvO2 may range from 35 to 55%. Particularly in 
functional univentricular circulation and also following Norwood procedure or its 
modifications central venous saturation (ScvO2) is used to assess the ratio between pulmonary 
and systemic flow. Arterial oxygen saturation of 75% and ScvO2 of 50% may be adequate. In 
this patient population it has been demonstrated that the risk of anaerobic metabolism 
increased from 4.8 % to 29% when ScvO2 fell below 30%.[16]..Reliable detecting oxygen 
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saturation values among 50 % is therefore mandatory for systems measuring SvO2 
continuously, to support decision making for adequate treatment options. In this setting the 
PediaSat system did not reliably estimate SvO2 values, and may contributes to miss necessary 
therapeutic interventions. 
In the past, several related systems have been investigated and the most recent studies show 
similar variations in the SvO2 range of interest [8, 10-13, 17]. In a previous investigation [11] 
we reported on a three light reference wave-length based oximetry catheter system 
demonstrating only a poor agreement between fibre-optically measured SO2 and SCO-OXO2 
values. Because of a nearly linear dependency of the mean difference between oxymetrically 
measured SO2 and SCO-OXO2 values in this study a systematic error has been assumed. Huber 
and colleagues [13] reported in an in vitro setting an excellent correlation between fibre-optic 
measurements of two different fibre-optic catheters and SCO-OXO2. However, the Bland-
Altman plots for both probes revealed high limits of agreement and demonstrated substantial 
overestimation of low SO2 and underestimation at high SO2. In a clinical investigation of a 
PediaSat system in neonates and paediatric patients undergoing cardiac surgery Ranucci and 
colleagues [17] reported a mean bias closed to zero and an acceptable value of percentage 
error (17.3 to 23.2%) between SPediSatO2 and SCO-OXO2 for measurements before, during and 
after cardiopulmonary bypass. They concluded that the PediaSat system might be considered 
as an accurate tool for continuous measurement of the ScvO2 in paediatric patients undergoing 
cardiac surgery. Most recently Spenceley and colleagues [12] reported in critically ill children 
a mean bias of 1.1% and inadmissible high limits of agreement (-15.8 and +18%) between 
fibre-optic measured SO2 values of the PediaSat system and SCO-OXCO2. Although the 
unacceptable high limits of agreement the authors deduced that the PediaSat system provided 
accurate trending of continuous ScvO2 but only within physiologic range. Whereas the results 
of the subgroup analysis of SCO-OXO2 values above 70% in the current in-vitro set up agreed 
well with those by Ranucci and colleagues [17], the SCO-OXO2 values between 70 to 25% were 
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not sufficiently detected. Contrary to our investigation the lowest SCO-OXO2 values achieved in 
the study by Ranucci and colleagues [17], and Spenceley and colleagues [12] were only close 
to 50%, which may explain the considerably disagreement with the presented findings.     
Although the PediaSat system demonstrated a substantial overestimation of SCO-OXO2 values < 
70% in the current investigation, sensitivity and specificity of SPediSatO2 to indicate 
deterioration or improvement of SvO2 were excellent. These findings may suggest that the 
PediaSat system might be a useful tool to indicate accurate trend of ScvO2. 
Our bench-top model only used variations in oxygen saturation and tried to maintain other 
parameters constant. Consequently,there is no further information about the performance 
during changes of haemoglobin, use of volume expanders, temperature shifts, metabolic 
disturbances and coagulation disorders. However, the used 1-way bench-top model clearly 
demonstrated inaccuracy of the system in the clinically relevant range of ScvO2 even under 
otherwise constant conditions. 
Based on our in-vitro findings, the new PediaSat system cannot be recommended as a reliable 
replacement of repeated invasive ScvO2 assessment in the clinically relevant range of ScvO2. 
Probably, rapid changes associated with haemodynamic deterioration and after resuscitation 
may be detected by the system. 
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Tables 
 
Table 1 Metabolic parameter. Values are expressed as mean and SD 
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Figures 
 
Fig 1 Experimental set-up: position of the two PediaSat fibre-optic probes in a light-protected 
black box integrated into an extracorporeal circuit. 
 
Fig 2 Linear regression plot and Bland-Altman for interprobe comparison (SpediaSatO2-Vigileo 
I and SpediaSatO2-Vigileo II) (n = 16; r2 = 0.99; p< 0.0001; bias= 4%; precision 4%)  
 
Fig 3 Linear regression plot and Bland-Altman for comparison of SpediaSatO2 values and SCO-
OXO2 measured by co-oximetry (n = 50; r2 = 0.96; bias +2.9%; 95 % limits of agreement–6.8 / 
+12.6%) 
 
Fig 4 Bland-Altman plots for comparison of SpediaSatO2 values and SCO-OXO2 measured by co-
oximetry for SO2 values > 70% and (n = 24; bias +0.4%; 95% limits of agreement –6.0 / 
+6.8%) and < 70% (n = 26; bias +5.2%; 95 % limits of agreement–4.7 / +15.1%) 
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Table 1  
 
Parameter        
Temperature, °C   36.8 (0.27)  
Hb, g.dl-1    8.0 (0.9)  
Hct, %     23.0 (1.3)  
PCO2, kPa    5.54 (0.56)  
pH     7.33 (0.03)  
HCO3, mmol/l   21.3 (2.5) 
BE, mmol/l    -3.9 (0.3) 
 
Abbreviations: Temp, temperature; Hb, haemoglobin; Hct, haematocrit; PCO2, partial dioxide 
tension; BE, Base excess.  
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 Fig 1  
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Fig 2:  
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Fig 3  
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Fig 4.  
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